Selected research
Market Structure
Global Pet Disease Diagnostic Reagent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pet Disease Diagnostic Reagent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pet Disease Diagnostic Reagent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pet Disease Diagnostic Reagent include Nanjing Synthgene Medical Technology, USTAR BIOTECHNOLOGIES (HANGZHOU), Hangzhou LifeReal Biotechnology, Harbin Guosheng Biomedical Laboratory, Idvet, IDEXX, Diogene and Bio-Rad, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pet Disease Diagnostic Reagent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pet Disease Diagnostic Reagent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pet Disease Diagnostic Reagent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Disease Diagnostic Reagent market size, projected growth trends, production technologies, key applications, and end-use industries.
Pet Disease Diagnostic Reagent Segment by Company
Nanjing Synthgene Medical Technology
USTAR BIOTECHNOLOGIES (HANGZHOU)
Hangzhou LifeReal Biotechnology
Harbin Guosheng Biomedical Laboratory
Idvet
IDEXX
Diogene
Bio-Rad
Pet Disease Diagnostic Reagent Segment by Type
Nucleic Acid Detection Reagents
Colloidal Gold Detection Reagents
Enzyme-linked Immunosorbent Assay Reagents
Fluorescent PCR Detection Reagents
Pet Disease Diagnostic Reagent Segment by Application
Cat
Dog
Others
Pet Disease Diagnostic Reagent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Diagnostic Reagent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Diagnostic Reagent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Diagnostic Reagent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pet Disease Diagnostic Reagent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Disease Diagnostic Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Disease Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pet Disease Diagnostic Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Detection Reagents
- Colloidal Gold Detection Reagents
- Enzyme-linked Immunosorbent Assay Reagents
- Fluorescent PCR Detection Reagents
Applications
- Cat
- Dog
- Others
Companies covered
- Nanjing Synthgene Medical Technology
- USTAR BIOTECHNOLOGIES (HANGZHOU)
- Hangzhou LifeReal Biotechnology
- Harbin Guosheng Biomedical Laboratory
- Idvet
- IDEXX
- Diogene
- Bio-Rad
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pet Disease Diagnostic Reagent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pet Disease Diagnostic Reagent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pet Disease Diagnostic Reagent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pet Disease Diagnostic Reagent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pet Disease Diagnostic Reagent Market Dynamics
- 2.1 Pet Disease Diagnostic Reagent Industry Trends
- 2.2 Pet Disease Diagnostic Reagent Industry Drivers
- 2.3 Pet Disease Diagnostic Reagent Industry Opportunities and Challenges
- 2.4 Pet Disease Diagnostic Reagent Industry Restraints
3 Pet Disease Diagnostic Reagent Market by Manufacturers
- 3.1 Global Pet Disease Diagnostic Reagent Revenue by Manufacturers (2021-2026)
- 3.2 Global Pet Disease Diagnostic Reagent Sales by Manufacturers (2021-2026)
- 3.3 Global Pet Disease Diagnostic Reagent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pet Disease Diagnostic Reagent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pet Disease Diagnostic Reagent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pet Disease Diagnostic Reagent Manufacturers, Product Type & Application
- 3.7 Global Pet Disease Diagnostic Reagent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pet Disease Diagnostic Reagent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pet Disease Diagnostic Reagent Players Market Share by Revenue in 2025
- 3.8.3 2025 Pet Disease Diagnostic Reagent Tier 1, Tier 2, and Tier 3
4 Pet Disease Diagnostic Reagent Market by Type
- 4.1 Pet Disease Diagnostic Reagent Type Introduction
- 4.1.1 Nucleic Acid Detection Reagents
- 4.1.2 Colloidal Gold Detection Reagents
- 4.1.3 Enzyme-linked Immunosorbent Assay Reagents
- 4.1.4 Fluorescent PCR Detection Reagents
- 4.2 Global Pet Disease Diagnostic Reagent Sales by Type
- 4.2.1 Global Pet Disease Diagnostic Reagent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pet Disease Diagnostic Reagent Sales by Type (2021-2032)
- 4.2.3 Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2021-2032)
- 4.3 Global Pet Disease Diagnostic Reagent Revenue by Type
- 4.3.1 Global Pet Disease Diagnostic Reagent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pet Disease Diagnostic Reagent Revenue by Type (2021-2032)
- 4.3.3 Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2021-2032)
5 Pet Disease Diagnostic Reagent Market by Application
- 5.1 Pet Disease Diagnostic Reagent Application Introduction
- 5.1.1 Cat
- 5.1.2 Dog
- 5.1.3 Others
- 5.2 Global Pet Disease Diagnostic Reagent Sales by Application
- 5.2.1 Global Pet Disease Diagnostic Reagent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pet Disease Diagnostic Reagent Sales by Application (2021-2032)
- 5.2.3 Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2021-2032)
- 5.3 Global Pet Disease Diagnostic Reagent Revenue by Application
- 5.3.1 Global Pet Disease Diagnostic Reagent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pet Disease Diagnostic Reagent Revenue by Application (2021-2032)
- 5.3.3 Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2021-2032)
6 Global Pet Disease Diagnostic Reagent Sales by Region
- 6.1 Global Pet Disease Diagnostic Reagent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pet Disease Diagnostic Reagent Sales by Region (2021-2032)
- 6.2.1 Global Pet Disease Diagnostic Reagent Sales by Region (2021-2026)
- 6.2.2 Global Pet Disease Diagnostic Reagent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pet Disease Diagnostic Reagent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pet Disease Diagnostic Reagent Revenue by Region
- 7.1 Global Pet Disease Diagnostic Reagent Revenue by Region
- 7.1.1 Global Pet Disease Diagnostic Reagent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pet Disease Diagnostic Reagent Revenue by Region (2021-2026)
- 7.1.3 Global Pet Disease Diagnostic Reagent Revenue by Region (2027-2032)
- 7.1.4 Global Pet Disease Diagnostic Reagent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pet Disease Diagnostic Reagent Revenue (2021-2032)
- 7.2.2 North America Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pet Disease Diagnostic Reagent Revenue (2021-2032)
- 7.3.2 Europe Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pet Disease Diagnostic Reagent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pet Disease Diagnostic Reagent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Nanjing Synthgene Medical Technology
- 8.1.1 Nanjing Synthgene Medical Technology Company Information
- 8.1.2 Nanjing Synthgene Medical Technology Business Overview
- 8.1.3 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Portfolio
- 8.1.5 Nanjing Synthgene Medical Technology Recent Developments
- 8.2 USTAR BIOTECHNOLOGIES (HANGZHOU)
- 8.2.1 USTAR BIOTECHNOLOGIES (HANGZHOU) Company Information
- 8.2.2 USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview
- 8.2.3 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Portfolio
- 8.2.5 USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments
- 8.3 Hangzhou LifeReal Biotechnology
- 8.3.1 Hangzhou LifeReal Biotechnology Company Information
- 8.3.2 Hangzhou LifeReal Biotechnology Business Overview
- 8.3.3 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Portfolio
- 8.3.5 Hangzhou LifeReal Biotechnology Recent Developments
- 8.4 Harbin Guosheng Biomedical Laboratory
- 8.4.1 Harbin Guosheng Biomedical Laboratory Company Information
- 8.4.2 Harbin Guosheng Biomedical Laboratory Business Overview
- 8.4.3 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Portfolio
- 8.4.5 Harbin Guosheng Biomedical Laboratory Recent Developments
- 8.5 Idvet
- 8.5.1 Idvet Company Information
- 8.5.2 Idvet Business Overview
- 8.5.3 Idvet Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Idvet Pet Disease Diagnostic Reagent Product Portfolio
- 8.5.5 Idvet Recent Developments
- 8.6 IDEXX
- 8.6.1 IDEXX Company Information
- 8.6.2 IDEXX Business Overview
- 8.6.3 IDEXX Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 IDEXX Pet Disease Diagnostic Reagent Product Portfolio
- 8.6.5 IDEXX Recent Developments
- 8.7 Diogene
- 8.7.1 Diogene Company Information
- 8.7.2 Diogene Business Overview
- 8.7.3 Diogene Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Diogene Pet Disease Diagnostic Reagent Product Portfolio
- 8.7.5 Diogene Recent Developments
- 8.8 Bio-Rad
- 8.8.1 Bio-Rad Company Information
- 8.8.2 Bio-Rad Business Overview
- 8.8.3 Bio-Rad Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bio-Rad Pet Disease Diagnostic Reagent Product Portfolio
- 8.8.5 Bio-Rad Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pet Disease Diagnostic Reagent Value Chain Analysis
- 9.1.1 Pet Disease Diagnostic Reagent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pet Disease Diagnostic Reagent Production Mode & Process
- 9.2 Pet Disease Diagnostic Reagent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pet Disease Diagnostic Reagent Distributors
- 9.2.3 Pet Disease Diagnostic Reagent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst